Wound healing delays in α-Klotho-deficient mice that have skin appearance similar to that in aged humans - Study of delayed wound healing mechanism

Biochemical and Biophysical Research Communications

Volumn 473, Issue 4, 2016, Pages 845-852

  Yamauchi, Makoto ^a   Hirohashi, Yoshihiko ^a   Torigoe, Toshihiko ^a   Matsumoto, Yoshitaka ^a   Yamashita, Ken ^a   Kayama, Musashi ^a   Sato, Noriyuki ^a   Yotsuyanagi, Takatoshi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

FGF23; Klotho; TNF ; Wound healing

Indexed keywords

ALPA KLOTHO PROTEIN; COLLAGEN GEL; FIBROBLAST GROWTH FACTOR 23; INTERLEUKIN 1BETA; INTERLEUKIN 6; KLOTHO PROTEIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BETA GLUCURONIDASE; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CUTANEOUS PARAMETERS; CYTOKINE PRODUCTION; FEMALE; FIBROBLAST; GRANULATION TISSUE; INFLAMMATION; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DEFECT; SKIN GRAFT; SPLEEN CELL; WOUND CLOSURE; WOUND HEALING IMPAIRMENT; AGING; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; INJURIES; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN; SPECIES DIFFERENCE; TRANSGENIC MOUSE; TREATMENT OUTCOME; WOUND HEALING;

AGING; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GLUCURONIDASE; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; SKIN; SPECIES SPECIFICITY; TREATMENT OUTCOME; WOUND HEALING;

EID: 84964933265     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.03.138     Document Type: Article

References (24)

1. M. Kuro-o, Y. Matsumura, H. Aizawa, H. Kawaguchi, T. Suga, T. Utsugi, Y. Ohyama, M. Kurabayashi, T. Kaname, E. Kume, H. Iwasaki, A. Iida, T. Shiraki-Iida, S. Nishikawa, R. Nagai, and Y.I. Nabeshima Mutation of the mouse klotho gene leads to a syndrome resembling ageing Nature 390 1997 45 51
2. K. Yamashita, T. Yotsuyanagi, M. Yamauchi, and D.M. Young Klotho mice: a novel wound model of aged skin Plast. Reconstr. Surg. Glob. Open 2 2014 e101
3. K. Morishita, A. Shirai, M. Kubota, Y. Katakura, Y. Nabeshima, K. Takeshige, and T. Kamiya The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc J. Nutr. 131 2001 3182 3188
4. M. Nakatsugawa, Y. Hirohashi, T. Torigoe, H. Asanuma, A. Takahashi, S. Inoda, K. Kiriyama, E. Nakazawa, K. Harada, H. Takasu, Y. Tamura, K. Kamiguchi, N. Shijubo, R. Honda, N. Nomura, T. Hasegawa, H. Takahashi, and N. Sato Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4 Cancer Sci. 100 2009 1485 1493
5. S. Barrientos, O. Stojadinovic, M.S. Golinko, H. Brem, and M. Tomic-Canic Growth factors and cytokines in wound healing Wound Repair Regen. 16 2008 585 601
6. I. Urakawa, Y. Yamazaki, T. Shimada, K. Iijima, H. Hasegawa, K. Okawa, T. Fujita, S. Fukumoto, and T. Yamashita Klotho converts canonical FGF receptor into a specific receptor for FGF23 Nature 444 2006 770 774
7. H. Kurosu, Y. Ogawa, M. Miyoshi, M. Yamamoto, A. Nandi, K.P. Rosenblatt, M.G. Baum, S. Schiavi, M.C. Hu, O.W. Moe, and M. Kuro-o Regulation of fibroblast growth factor-23 signaling by klotho J. Biol. Chem. 281 2006 6120 6123
8. C. Faul, A.P. Amaral, B. Oskouei, M.C. Hu, A. Sloan, T. Isakova, O.M. Gutierrez, R. Aguillon-Prada, J. Lincoln, J.M. Hare, P. Mundel, A. Morales, J. Scialla, M. Fischer, E.Z. Soliman, J. Chen, A.S. Go, S.E. Rosas, L. Nessel, R.R. Townsend, H.I. Feldman, M. St John Sutton, A. Ojo, C. Gadegbeku, G.S. Di Marco, S. Reuter, D. Kentrup, K. Tiemann, M. Brand, J.A. Hill, O.W. Moe, O.M. Kuro, J.W. Kusek, M.G. Keane, and M. Wolf FGF23 induces left ventricular hypertrophy J. Clin. Invest. 121 2011 4393 4408
9. H. Liu, M.M. Fergusson, R.M. Castilho, J. Liu, L. Cao, J. Chen, D. Malide, Rovira II, D. Schimel, C.J. Kuo, J.S. Gutkind, P.M. Hwang, and T. Finkel Augmented Wnt signaling in a mammalian model of accelerated aging Science 317 2007 803 806
10. M. Kuro-o Klotho Pflugers Arch. 459 2010 333 343
11. L. Hoareau, K. Bencharif, P. Rondeau, R. Murumalla, P. Ravanan, F. Tallet, P. Delarue, M. Cesari, R. Roche, and F. Festy Signaling pathways involved in LPS induced TNFalpha production in human adipocytes J. Inflamm. Lond. 7 2010 1
12. D.A. Weinstein, and R.S. Kirsner Refractory ulcers: the role of tumor necrosis factor-alpha J. Am. Acad. Dermatol. 63 2010 146 154
13. J. Vilcek, V.J. Palombella, D. Henriksen-DeStefano, C. Swenson, R. Feinman, M. Hirai, and M. Tsujimoto Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors J. Exp. Med. 163 1986 632 643
14. M. Frater-Schroder, W. Risau, R. Hallmann, P. Gautschi, and P. Bohlen Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo Proc. Natl. Acad. Sci. U. S. A. 84 1987 5277 5281
15. V.A. Polunovsky, C.H. Wendt, D.H. Ingbar, M.S. Peterson, and P.B. Bitterman Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis Exp. Cell Res. 214 1994 584 594
16. A. Ito, T. Sato, T. Iga, and Y. Mori Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts FEBS Lett. 269 1990 93 95
17. N.J. Trengove, M.C. Stacey, S. MacAuley, N. Bennett, J. Gibson, F. Burslem, G. Murphy, and G. Schultz Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors Wound Repair Regen. 7 1999 442 452
18. N.J. Trengove, H. Bielefeldt-Ohmann, and M.C. Stacey Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers Wound Repair Regen. 8 2000 13 25
19. I. Goren, E. Muller, D. Schiefelbein, U. Christen, J. Pfeilschifter, H. Muhl, and S. Frank Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages J. Invest. Dermatol. 127 2007 2259 2267
20. X. Zhang, O.A. Ibrahimi, S.K. Olsen, H. Umemori, M. Mohammadi, and D.M. Ornitz Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family J. Biol. Chem. 281 2006 15694 15700
21. D.M. Ornitz FGFs, heparan sulfate and FGFRs: complex interactions essential for development Bioessays 22 2000 108 112
22. J. Munoz Mendoza, T. Isakova, A.C. Ricardo, H. Xie, S.D. Navaneethan, A.H. Anderson, L.A. Bazzano, D. Xie, M. Kretzler, L. Nessel, L.L. Hamm, L. Negrea, M.B. Leonard, D. Raj, and M. Wolf Chronic renal insufficiency, fibroblast growth factor 23 and inflammation in CKD Clin. J. Am. Soc. Nephrol. 7 2012 1155 1162
23. H. Komaba, S. Goto, H. Fujii, Y. Hamada, A. Kobayashi, K. Shibuya, Y. Tominaga, N. Otsuki, K. Nibu, K. Nakagawa, N. Tsugawa, T. Okano, R. Kitazawa, M. Fukagawa, and T. Kita Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients Kidney Int. 77 2010 232 238
24. T. Isakova, P. Wahl, G.S. Vargas, O.M. Gutierrez, J. Scialla, H. Xie, D. Appleby, L. Nessel, K. Bellovich, J. Chen, L. Hamm, C. Gadegbeku, E. Horwitz, R.R. Townsend, C.A. Anderson, J.P. Lash, C.Y. Hsu, M.B. Leonard, and M. Wolf Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease Kidney Int. 79 2011 1370 1378